Structured intelligence: How AI is transforming high-stakes R&D decisions

The signals that matter most are the ones you don’t know to look for

You scan the journals your team follows, track the keywords you’ve identified, and make high-stakes investment calls based on what that process surfaces. Which means you’re also making them based on what it misses.

Quotes icon
To get outside of my keywords, I need something different. If I think of AI in the narrow sense of generative AI, I don’t think it’s going to help us find the unknown unknowns.”
R&D research strategist

Get your free copy here

Find out how R&D leaders in pharma, chemicals, and technology are using structured intelligence to make better investment decisions — delivered straight to your inbox.

This whitepaper is for you if…

You’re an R&D leader who makes high-stakes investment decisions in pharma, chemicals, or technology.

  • You lead R&D strategy and your tools still depend on the keywords and competitors you already know
  • You work in research analytics and aren’t convinced generative AI alone gets you to the insights that matter
  • You’re a portfolio leader who has seen good data fail to shift a decision

What you’ll discover

What structured intelligence means in practice — and what separates organisations building a real analytical edge from those still running keyword searches.

  • How knowledge graphs surface connections and weak signals no keyword search would find
  • How AI can generate competing hypotheses that introduce productive challenge rather than reinforce existing views
  • What organizational readiness actually requires, starting with the data foundation